How will drug and device makers fare under Clinton's reform plan?
R
R
Blankenau
D003363:Cost Control / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends; D004864:Equipment and Supplies / Q000191:economics*; D005249:Fees and Charges / Q000331:legislation & jurisprudence; D005544:Forecasting; D018166:Health Care Reform / Q000639:trends*; D007221:Industry / Q000639:trends*; D014481:United States